PhaseBio Pharmaceuticals, Inc. (PHAS)
SG&A Expenses
$1.25M
TTM · Period ending: · USD
PHAS SG&A Expenses
Latest reported$1.25Mperiod ending
Latest reported$1.25Mperiod ending
PHAS SG&A Expenses ($2.13M → $1.25M)
Annual SG&A Expenses
High-resolution chart · PNG
PHAS sg&a expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 16,086 | |
| 13,088,000 | |
| 11,186,000 | |
| 4,857,000 | |
| 2,328,000 | |
| 2,125,000 |